General
 |
|
10 january 2019 11:00:14 |
| Efficacy, safety, and resistance profile of osimertinib in T790M mutation-positive non-small cell lung cancer in real-world practice (PLoS ONE) |
|
Tweet |
| 63 viewsCategory: Biology, Chemistry, General |
 Risk interval analysis of emergency room visits following colonoscopy in patients with inflammatory bowel disease (PLoS ONE)Prognostic value of baseline metabolic tumor volume and total lesion glycolysis in patients with lymphoma: A meta-analysis (PLoS ONE) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
